Filed: 4/3/2025ACC: 0000950123-25-003299
📋 What this filing means
VIDA VENTURES ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $13.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$13.64M
Total AUM (reported)
9.09M
Total Shares
Allocation by class
COMMON STOCK$13.64M100.0%
Portfolio Concentration
Top 3$13.64M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.09M
Sole
Full voting authority
9.09M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
Kyverna Therapeutics, Inc.
SOLEShares4.52M
TypeSH
Market value$8.73M
64.02%
Sole
4.52M
Shared
0.00
None
0.00
Allogene Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$2.63M
19.25%
Sole
1.80M
Shared
0.00
None
0.00
Kronos Bio, Inc.
SOLEShares2.77M
TypeSH
Market value$2.28M
16.73%
Sole
2.77M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Kyverna Therapeutics, Inc.SOLE | Common Stock | 4.52M | SH | $8.73M 64.02% | 4.52M | 0.00 | 0.00 |
Allogene Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $2.63M 19.25% | 1.80M | 0.00 | 0.00 |
Kronos Bio, Inc.SOLE | Common Stock | 2.77M | SH | $2.28M 16.73% | 2.77M | 0.00 | 0.00 |